Point72 Asset Management, L.P. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:06 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 493,400 0.900% |
-3,021,956 (-85.96%) |
Filing |
| 2023-02-14 4:25 pm Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,515,356 7.100% |
116,695 (+3.43%) |
Filing |
| 2022-11-14 5:11 pm Purchase |
2022-11-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Point72 Asset Management, L.P. | 3,398,661 7.100% |
3,398,661 (New Position) |
Filing |